HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neonatal brachial plexus palsy with vaginal birth after cesarean delivery: a case-control study.

AbstractOBJECTIVE:
The objective was to determine the rate of neonatal brachial plexus palsy (NBPP) among women with vaginal birth after cesarean delivery (VBAC) and to compare the peripartum characteristics with control subjects.
STUDY DESIGN:
The Maternal-Fetal Medicine Unit cesarean registry data were used to identify nonanomalous singleton pregnancies with VBAC and NBPP at gestational age of ≥37 weeks (term) and 4 control subjects (matched for gestational age and diabetes mellitus status but without brachial injury). Odds ratio (OR) and 95% confidence intervals (CIs) were calculated.
RESULTS:
Among 11,313 VBACs at term, there were 23 women with NBPP (rate of 2.0/1000 women). Newborn infants with NBPP, compared with control infants, were significantly more likely to weigh ≥4000 g (48% vs 10%, respectively; OR, 8.45; 95% CI, 2.58-28.44) and to require admission to the neonatal intensive care unit (30% vs 13%; OR, 12.98; 95% CI, 2.61-72.18).
CONCLUSION:
Women who desire VBAC should be informed about the low rate of NBPP and, if eligible, encouraged to have a trial of labor after cesarean delivery.
AuthorsIbrahim A Hammad, Suneet P Chauhan, Robert B Gherman, Joseph G Ouzounian, James B Hill, Alfred Z Abuhamad
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 208 Issue 3 Pg. 229.e1-5 (Mar 2013) ISSN: 1097-6868 [Electronic] United States
PMID23211545 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Mosby, Inc. All rights reserved.
Topics
  • Adult
  • Birth Injuries (etiology)
  • Brachial Plexus Neuropathies (etiology)
  • Case-Control Studies
  • Female
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Risk
  • Trial of Labor
  • Vaginal Birth after Cesarean (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: